IL17A and psoriasis: Recapitulating psoriasis skin, IL-17A+TNF-α treatment lead to increased expression of DEFB4, PI3, LCN2, S100A7, and IL36G mRNA over a 72 h time course (Fig 1) without marked deterioration of tissue structure (S1 Fig).